These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16053333)

  • 1. PAMAM dendrimer based macromolecules as improved contrast agents.
    Venditto VJ; Regino CA; Brechbiel MW
    Mol Pharm; 2005; 2(4):302-11. PubMed ID: 16053333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices.
    Shi X; Majoros IJ; Baker JR
    Mol Pharm; 2005; 2(4):278-94. PubMed ID: 16053331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer cells with biotin-dendrimer conjugates.
    Yang W; Cheng Y; Xu T; Wang X; Wen LP
    Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
    Patri AK; Kukowska-Latallo JF; Baker JR
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
    Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
    Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoscale protein pores modified with PAMAM dendrimers.
    Martin H; Kinns H; Mitchell N; Astier Y; Madathil R; Howorka S
    J Am Chem Soc; 2007 Aug; 129(31):9640-9. PubMed ID: 17636906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
    Tomalia DA; Reyna LA; Svenson S
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
    Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA
    Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrimer-based BH3 conjugate that targets human carcinoma cells.
    Myc A; Patri AK; Baker JR
    Biomacromolecules; 2007 Oct; 8(10):2986-9. PubMed ID: 17877400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphinic derivative of DTPA conjugated to a G5 PAMAM dendrimer: an 17O and 1H relaxation study of its Gd(III) complex.
    Lebdusková P; Sour A; Helm L; Tóth E; Kotek J; Lukes I; Merbach AE
    Dalton Trans; 2006 Jul; (28):3399-406. PubMed ID: 16832488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendrimers: Analytical characterization and applications.
    Biricova V; Laznickova A
    Bioorg Chem; 2009 Dec; 37(6):185-92. PubMed ID: 19703699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-sized MRI contrast agents with dendrimer cores.
    Kobayashi H; Brechbiel MW
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2271-86. PubMed ID: 16290152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assemblies of dendrimers and proteins on carbon and gold electrodes.
    Lojou E; Bianco P
    Bioelectrochemistry; 2006 Oct; 69(2):237-47. PubMed ID: 16707279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An iron(III) selective dendrite chelator based on polyamidoamine dendrimer modified with 4-bromo-1,8-naphthalimide.
    Grabchev I; Chovelon JM; Petkov C
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jan; 69(1):100-4. PubMed ID: 17451996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention.
    McCarthy TD; Karellas P; Henderson SA; Giannis M; O'Keefe DF; Heery G; Paull JR; Matthews BR; Holan G
    Mol Pharm; 2005; 2(4):312-8. PubMed ID: 16053334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendrimers in biomedical applications--reflections on the field.
    Svenson S; Tomalia DA
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2106-29. PubMed ID: 16305813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic and diagnostic applications of dendrimers for cancer treatment.
    Wolinsky JB; Grinstaff MW
    Adv Drug Deliv Rev; 2008 Jun; 60(9):1037-55. PubMed ID: 18448187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.
    Majoros IJ; Thomas TP; Mehta CB; Baker JR
    J Med Chem; 2005 Sep; 48(19):5892-9. PubMed ID: 16161993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of heterogeneously functionalized dendrimers by mass spectrometry and EPR spectroscopy.
    Walter ED; Sebby KB; Usselman RJ; Singel DJ; Cloninger MJ
    J Phys Chem B; 2005 Nov; 109(46):21532-8. PubMed ID: 16853796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
    Yiyun C; Tongwen X
    Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.